Created at Source Raw Value Validated value
Feb. 26, 2022, 7:30 p.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group: Injection of 1 dose of Pastocovac vaccine as a booster dose, 3-6 months after receiving 2 doses of Sinopharm vaccine. The Pastocovac vaccine, produced by the Pasteur Institute of Iran, is injected intramuscularly into the deltoid muscle (0.5 ml, containing 25 micrograms of RBD conjugated with tetanus).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionControl group 1: injection of 1 dose of Pastocovac-Plus vaccine as a booster dose, 3-6 months after receiving 2 doses of Sinopharm vaccine. Pastocovac vaccine, produced by the Pasteur Institute of Iran, is injected intramuscularly into the deltoid muscle (0.5 ml, containing 50 micrograms of RBD dimer).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionControl group 2: injection of 1 dose of Sinopharm vaccine as a booster dose, 3-6 months after receiving 2 doses of Sinopharm vaccine. The Sinopharm vaccine, produced by the Beijing Institute of Biological Products, is injected intramuscularly into the deltoid muscle (containing 6.5 units of inactivated virus).", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 2438, "treatment_name": "Pastocovac", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2439, "treatment_name": "Pastocovac-plus", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]